• Updated

The World Health Organization reports that five patients have recovered from a rare type of Ebola virus in eastern Congo. WHO Director-General Tedros Adhanom Ghebreyesus announced the recoveries during a visit to Bunia, the provincial capital of Ituri. The Bundibugyo virus, the current species of Ebola, has no approved treatment or vaccine. Despite improved health facilities, the virus is spreading faster than the response. Doctors Without Borders is calling for expanded testing and faster aid deployment. Local anger over burial protocols has led to attacks on health centers. WHO is emphasizing community involvement in the outbreak response.

New research shows a novel pill is helping people with advanced pancreatic cancer live longer. It's not a cure, as the drug's effects eventually waned. But it's a very different kind of treatment than the chemotherapy that is a mainstay for these patients. Called daraxonrasib, the drug is designed to block a mutated protein that fuels most cases of pancreatic cancer, one of the deadliest types of cancer. The research was published Sunday in the New England Journal of Medicine and presented at an American Society of Oncology meeting. Maker Revolution Medicines will seek Food and Drug Administration approval.

  • Updated

Health workers responding to a rapidly spreading outbreak of a rare type of Ebola in eastern Congo face two threats. They risk contracting the virus and encounter hostility from wary locals. Aid workers are especially vulnerable in this volatile region where armed groups have caused significant unrest. Trust is scarce among the traumatized population, complicating efforts to contain the outbreak. Healthcare facilities have been attacked at least three times in the past week, forcing evacuations and hindering response efforts. Gaining community trust is essential. The World Health Organization reports over 900 suspected Ebola cases and more than 220 deaths.